As you say, it is very important for Elite to get their product distributed quickly. Isradipine is one of many calcium channel blockers. There are subtle differences between the various drugs in this class, but people forced to change might never change back.
Elite launched Isradipine under its own label on April 1.
Epic is the distributor for Elite's isradipine. If Epic has discontinued our isradipine, then I presume it is in preparation for the move to Elite's own label.
And not listed in the orange book either https://www.accessdata.fda.gov/scripts/cder/ob/index.cfm I don't think Epic ever made it, that site is bogus, it also showes Lannett short of 25 mgs caps, has for 2months now, WRONG, ,,some intern must be doing research
The way I read Nasrat's input on this in the last CC is that it was supposed to be available in April. I can find it available to buy so there must be enough to keep customers afloat for awhile. I think it will be easy for Elite to convince pharmacies to buy their Adderall and Isradipine because they are crucial products for Elite. Teva doesn't really care if it loses a few dollars from Isradipine (they didn't even bother to explain why they were behind).
From last CC:
Isradipine and trumapramine will be sold under Elite's label as well as of April. Although modest in size, both products have only one or two competitors, therefore, the margins can be attractive. We believe that being directly involved in pricing will help Elite to increase the value of these products. Loxapine and Dantrolene will also be offered as of April 1 and under Elite's label.
Blurb about when Teva would have more from notice WeeZuhl referenced
Teva has isradipine 2.5 mg and 5 mg capsules in 100 count bottles on back order and the company estimates a release date in late-July 2023 for the 2.5 mg capsules and late-June for the 5 mg capsules.